Status:
UNKNOWN
Epigenetic Safety of Assisted Reproductive Technology
Lead Sponsor:
Women's Hospital School Of Medicine Zhejiang University
Collaborating Sponsors:
International Peace Maternity and Child Health Hospital
Changhai Hospital
Conditions:
Infertility
Eligibility:
All Genders
20-55 years
Brief Summary
The primary purpose of the study is to investigate the relationship between different protocols of assisted reproductive technology and the epigenetic safety of the offspring. Different interventions ...
Eligibility Criteria
Inclusion
- Couples undergoing treatment for infertility or getting pregnant naturally and wanting to deliver their babies in Women's Hospital School of Medicine Zhejiang University, The International Peace Maternity \& Child Health Hospital, and Changhai Hospital of Shanghai.
- Men 22-55 years old
- Women 20 - 45 years old
Exclusion
- Any individual or couple who is outside of age range .
- Any couple who don't plan to complete their pregnancy check-up or deliver their babies in Women's Hospital School of Medicine Zhejiang University, The International Peace Maternity \& Child Health Hospital, or Changhai Hospital of Shanghai.
Key Trial Info
Start Date :
September 15 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
15000 Patients enrolled
Trial Details
Trial ID
NCT04065945
Start Date
September 15 2019
End Date
December 31 2024
Last Update
August 22 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Women's Hospital School of Medicine Zhejiang University
Hangzhou, Zhejiang, China